Posted by Iansf on February 8, 2006, at 19:49:49
On December 29, the FDA approved a first-time generic formulation for cabergoline 0.5-mg tablets (made by Par Pharmaceutical, Inc; brand name Dostinex, made by Pfizer, Inc). Cabergoline tablets are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.
But some have suggested cabergoline can also be an effective antidote to med-induced sexual dysfunction.
poster:Iansf
thread:607682
URL: http://www.dr-bob.org/babble/20060205/msgs/607682.html